Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 8/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | BAD | Q92934 | 1/20 | 0.40 |
| ▸ | KMO | O15229 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346085 | 0.83 | ALDH1A1 (0.42) | ALDH1A1FFAR1TDP1CFTRAR | |
| SCHEMBL31346183 | 0.82 | KMO (0.56) | ALDH1A1FFAR1TDP1KMO | |
| SCHEMBL31346172 | 0.81 | ALDH1A1 (0.48) | ALDH1A1FFAR1TDP1ARKMO | |
| SCHEMBL31346099 | 0.80 | CFTR (0.49) | ALDH1A1FFAR1TDP1CFTRMRGPRX4 | |
| SCHEMBL31345978 | 0.80 | CFTR (0.49) | ALDH1A1FFAR1TDP1CFTRMRGPRX4 | |
| SCHEMBL31345983 | 0.78 | ALDH1A1 (0.45) | ALDH1A1FFAR1MAOBTDP1CFTR | |
| SCHEMBL31346163 | 0.78 | TDP1 (0.47) | ALDH1A1FFAR1MAOBTDP1MRGPRX4 | |
| SCHEMBL31346052 | 0.78 | TDP1 (0.47) | ALDH1A1FFAR1TDP1CFTRMRGPRX4 | |
| SCHEMBL31346166 | 0.77 | MRGPRX4 (0.45) | ALDH1A1FFAR1TDP1CFTRMRGPRX4 | |
| SCHEMBL31346154 | 0.77 | ALDH1A1 (0.49) | ALDH1A1FFAR1MAOBTDP1MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |